Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/80781
Title: Identification of a novel sequence type of Escherichia coli as the causative agent of pyelonephritis and bloodstream infection
Authors: Mac Aogáin, Micheál
Miajlovic, Helen
Moloney, Geraldine
Chotirmall, Sanjay Haresh
Rogers, Thomas R.
Smith, Stephen G. J.
Keywords: Escherichia coli ST-458
Bacteraemia
Issue Date: 2016
Source: Mac Aogáin, M., Miajlovic, H., Moloney, G., Chotirmall, S. H., Rogers, T. R., & Smith, S. G. J. (2016). Identification of a novel sequence type of Escherichia coli as the causative agent of pyelonephritis and bloodstream infection. JMM Case Reports, 3, 1-4.
Series/Report no.: JMM Case Reports
Abstract: Introduction: Globally, extra-intestinal pathogenic Escherichia coli are one of the predominant causative agents of bacteraemia. Case presentation: This case report outlines a presentation of community-acquired pyelonephritis and secondary bloodstream infection in an 81-year-old man. Laboratory investigations revealed that the causative isolate was a multi-drug-resistant E. coli of a novel multi-locus sequence type. This sequence type (ST) was designated ST-458 and was most closely related to the globally prevalent ST-131 lineage. Conclusion: This is the first report of a novel E. coli ST, ST-458, which caused pyelonephritis and bacteraemia.
URI: https://hdl.handle.net/10356/80781
http://hdl.handle.net/10220/42230
DOI: 10.1099/jmmcr.0.005061
Schools: Lee Kong Chian School of Medicine (LKCMedicine) 
Rights: © 2016 The Authors (published by Microbiology Society). This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/).
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:LKCMedicine Journal Articles

Page view(s) 50

567
Updated on Jun 16, 2024

Download(s) 50

136
Updated on Jun 16, 2024

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.